Claims for Patent: 5,599,906

Summary for Patent: 5,599,906

Title:	Protease assays
Abstract:	Hybrid regulatory proteins are provided which contain amino acid sequences that are susceptible to cleavage by specific proteolytic enzymes. When acted upon by such enzymes, the hybrid regulatory proteins are rendered substantially less active, thereby altering the rate of production of products of indicator genes that are controlled by the regulatory proteins. Also provided are DNAs encoding such regulatory proteins, recombinant vectors and transformed eukaryotic cells containing such DNAs, and methods for identifying inhibitors of the specific proteolytic enzymes.
Inventor(s):	Dasmahapatra; Bimalendu (Nutley, NJ)
Assignee:	Schering Corporation (Kenilworth, NJ)
Application Number:	08/333,901
Patent Claims:	1. A hybrid regulatory protein comprising a DNA-binding peptide and a DNA transcription-modifying peptide covalently joined in peptide linkage by a linker peptide which hybrid regulatory protein is (a) capable of binding to a specific region of DNA that controls the expression of one or more genes, thereby altering the rate of expression of the genes, and is (b) rendered substantially inactive by cleavage of the linker peptide by the protease, wherein substantially inactive means that the cleaved protein has 20% or less of the transcription-activating activity of the uncleaved, intact protein. 2. A hybrid regulatory protein of claim 1 wherein the linker peptide is cleaved by Coxsackievirus 3C protease, HIV-1 protease or collagenase. 3. A hybrid regulatory protein of claim 1 which is a repressor of DNA transcription. 4. A hybrid regulatory protein of claim 1 which is an activator of DNA transcription. 5. A hybrid regulatory protein of claim 1 wherein the DNA-binding peptide and the DNA transcription-modifying peptide comprise amino acid residues 1-147 and 768-881, respectively, of GAL4 (SEQ ID NO: 1). 6. A hybrid regulatory protein of claim 1 wherein the linker peptide is cleaved by Coxsackievirus 3C protease. 7. A hybrid regulatory protein of claim 1 wherein the linker peptide is susceptible to cleavage by HIV-1 protease.

Details for Patent 5,599,906

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2014-02-04